CardioExchange Archive

February 22nd, 2012

Part 5: Clashing Views of Appropriate Use Criteria for PCI

Paul S. Chan, MD, MS, Steve Marso, MD, John Spertus, MD, MPH and J Aaron Grantham, MD, FACC

In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]

---

February 21st, 2012

Part 4: Clashing Views of Appropriate Use Criteria for PCI

Steve Marso, MD, J Aaron Grantham, MD, FACC, Paul S. Chan, MD, MS and John Spertus, MD, MPH

In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]

---

February 17th, 2012

Part 3: Clashing Views of Appropriate Use Criteria for PCI

John Spertus, MD, MPH, Steve Marso, MD, J Aaron Grantham, MD, FACC and Paul S. Chan, MD, MS

In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]

---

February 16th, 2012

Part 2: Clashing Views of Appropriate Use Criteria for PCI

J Aaron Grantham, MD, FACC, John Spertus, MD, MPH, Steve Marso, MD and Paul S. Chan, MD, MS

In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange members for their […]

---

February 15th, 2012

Part 1: Clashing Views of Appropriate Use Criteria for PCI

Paul S. Chan, MD, MS, J Aaron Grantham, MD, FACC, Steve Marso, MD and John Spertus, MD, MPH

In a recent Viewpoint in JACC: Cardiovascular Interventions, Marso and colleagues expressed grave reservations about the application of appropriate use criteria for PCI in a controversial study published last year in JAMA by Chan and colleagues, which found that only half of PCIs performed for nonacute indications were classified as appropriate. Interventional cardiology editors Rick Lange and David Hillis asked CardioExchange […]

---

June 10th, 2010

Bleeding Avoidance Strategies in PCI

Steve Marso, MD

CardioExchange welcomes Dr. Steven Marso to answer questions about his recent paper in JAMA, which analyzed data from 1.5 million PCI patients from hospitals enrolled in the National Cardiovascular Data Registry (NCDR) to examine the use of bleeding-avoidance strategies. Manual compression was used in 35% of cases, vascular closure devices (VCDs) in 24%, bivalirudin in […]

---